Skip to main content

Law Offices of Howard G. Smith Encourages Embecta Corp. (EMBC) Shareholders To Inquire About Securities Fraud Class Action

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) common stock between November 25, 2025 and May 4, 2026, inclusive (the “Class Period”). Embecta investors have until August 17, 2026 to file a lead plaintiff motion.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN EMBECTA CORP. (EMBC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On May 5, 2026, Embecta released its second quarter fiscal 2026 financial results, revealing that revenue had declined over 14%, largely due to weakness in its pen needle sales. Additionally, the Company lowered its guidance for the remainder of fiscal 2026.

On this news, Embecta’s stock price fell $5.35, or 57.8%, to close at $3.90 per share on May 5, 2026, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company’s guidance was misleading and unattainable; (2) segment weakness, especially in the United States pen needle market, was likely to disrupt the Company’s original revenue guidance and second quarter 2026 results; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:

If you purchased Embecta common stock, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.11
+1.32 (0.57%)
AAPL  294.30
-2.71 (-0.91%)
AMD  519.85
-31.78 (-5.76%)
BAC  57.91
+0.54 (0.94%)
GOOG  346.08
-2.70 (-0.77%)
META  562.20
-1.65 (-0.29%)
MSFT  373.94
+6.60 (1.80%)
NVDA  200.04
-8.61 (-4.13%)
ORCL  165.16
-9.91 (-5.66%)
TSLA  381.61
-23.44 (-5.79%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.